RMTG
Regenerative Medical Technology Group Inc.
$0.03
0.00 (-1.69%)
At close · Jul 2
Going-concern doubt
— flagged Jun 9, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has incurred losses since inception, resulting in an accumulated deficit of $76,241,785 and a working capital deficit of $36,639,004 as of March 31, 2026, and future losses are anticipated. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Jun 9, 2026
3 Down Days
Indicators
Price
Panels
Event markers
Price & Indicators
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.03
Open$0.03
Day$0.03–0.03
52W$0.02–0.08
Avg vol 30d37K
Short int2K · 1.0d
Short vol30%
Last earningsMay 21, 2025
DataJan 2020–Jul 2026
Filing10-Q · Jun 9
Equibles Rating
blended score
Overall
Neutral
Technical · trend & momentum
Sell
−
Price vs 200-day avg · −30% below
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−30% below
−
Price vs 50-day avg
−21% below
◦
RSI (14)
41 · neutral
−
MACD trend
negative
◦
52-week position
17% · mid-range
Sentiment · smart money
Neutral
◦
Trend (MA cross) · 50d $0 › 200d $0 — 200d above 50d
◦
Trend (MA cross)
50d $0 › 200d $0 — 200d above 50d
◦
Institutional flow
No 13F holder data
◦
Insider flow
No net insider activity over 90 days
◦
Short interest
0.01% of float · ▬ 0.0% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
No 13F holder history
Fundamentals
Strong
+
Revenue growth · +24% Y/Y
+
Revenue growth
+24% Y/Y
+
Gross margin
55%, contracting
−
EPS growth
−41% Y/Y
−
Free cash flow
$-1.3M
+
Balance sheet
net cash $956.7K
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Key facts
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Jun 9, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−30% below
Bearish
Price vs 50-day avg
−21% below
Bearish
RSI (14)
41 · neutral
Neutral
MACD trend
negative
Bearish
52-week position
17% · mid-range
Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.01% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
52-wk low $0
Now $0 · 17%
52-wk high $0
vs 200-day avg -30%
vs 50-day avg -21%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RMTG
this stock
Regenerative Medical Technology Group Inc.
|
$381,030 | -40.8% | +24.2% | — | 0.0% |
|
AKTX
Akari Therapeutics Plc
|
$938.56B | -11.3% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.86B | -1.9% | +22179.2% | 958.2 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.40B | +9.8% | +46.2% | 29.6 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$66.52B | -19.1% | +20.8% | 15.5 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RMTG | -35.8% | -14.7% | -35.3% | -37.0% | -40.8% |
| SPY | +1.7% | -1.8% | +8.2% | -0.1% | +9.4% |
| vs SPY | -37.6% | -12.9% | -43.4% | -36.8% | -50.2% |